ASSET | DATE | % RETURN |
---|---|---|
Tango Therapeutics (TNGX) | 10/4/2022 - 10/21/2022 | 110.14% |
Biohaven Pharmaceutical (BHVN) | 10/4/2022 - 10/21/2022 | 92.88% |
Inventiva (IVA) | 10/4/2022 - 10/21/2022 | 68.42% |
Enliven Therapeutics (ELVN) | 10/4/2022 - 10/21/2022 | 68.24% |
Waldencast Acquisition (WALDW) | 10/4/2022 - 10/21/2022 | 67.5% |
Vigil Neuroscience (VIGL) | 10/4/2022 - 10/21/2022 | 62.11% |
89bio (ETNB) | 10/4/2022 - 10/21/2022 | 54.19% |
Value Line (VALU) | 10/4/2022 - 10/21/2022 | 51.4% |
ADEIA (ADEA) | 10/4/2022 - 10/21/2022 | 43.65% |
Byrna Technologies (BYRN) | 10/4/2022 - 10/21/2022 | 42.59% |
Autolus Therapeutics (AUTL) | 10/4/2022 - 10/21/2022 | 39.09% |
SS Innovations International Inc Common Stock (SSII) | 10/4/2022 - 10/21/2022 | 38.64% |
Aehr Test Systems (AEHR) | 10/4/2022 - 10/21/2022 | 36.7% |
Veris Residential (VRE) | 10/4/2022 - 10/21/2022 | 34.89% |
UroGen Pharma (URGN) | 10/4/2022 - 10/21/2022 | 33.53% |
Janux Therapeutics (JANX) | 10/4/2022 - 10/21/2022 | 33.38% |
Cricut (CRCT) | 10/4/2022 - 10/21/2022 | 31.01% |
Par Pacific (PARR) | 10/4/2022 - 10/21/2022 | 30.24% |
Kura Oncology (KURA) | 10/4/2022 - 10/21/2022 | 29.3% |
Riley Exploration Permian (REPX) | 10/4/2022 - 10/21/2022 | 29.22% |
Pacific Biosciences of California (PACB) | 10/4/2022 - 10/21/2022 | 28.86% |
Wave Life Sciences (WVE) | 10/4/2022 - 10/21/2022 | 28.85% |
American Public Education (APEI) | 10/4/2022 - 10/21/2022 | 28.6% |
Next Technology (NXTT) | 10/4/2022 - 10/21/2022 | 28.09% |
Waterdrop Inc ADR (WDH) | 10/4/2022 - 10/21/2022 | 27.93% |